https://www.selleckchem.com/products/tas-120.html
Recurrence occurred in 4 patients within 30 days, and the clinical success rate was 80%(16/2. Mild maxillofacial pain occurred in 5 patients (25.0%) and no serious complications occurred. Conclusion Emergency interventional embolization is safe and effective for the management of intractable tumor bleeding in head and neck cancer.Objective To explore the latest progress of oncology drug clinical trials in China under COVID-19, as well as to provide decision-making evidence for related stakeholders. Research progress of oncology drug t
Like
Comment
Share
